RBM12

RNA-binding protein 12 · Q9NTZ6 · RBM12 on Sugi Atlas →

0 patent compounds predicted against RBM12, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RBM12 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD) PHASE3COMPLETED
Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia PHASE2ACTIVE_NOT_RECRUITING
S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer PHASE2COMPLETED
AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease PHASE1RECRUITING
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Longitudinal Study of Neurogenetic Disorders nanRECRUITING
Epitranscriptomic Blood Biomarkers for Coronary Artery Disease - A Prospective Cohort Study (IHD-EPITRAN) nanUNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants nanRECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases nanRECRUITING
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Risk of HCC in Cirrhotic Patients Post DAAs Ttt nanUNKNOWN
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Timisnar - Biomarkers Substudy (Timisnar-mirna) nanUNKNOWN
Research for Individualized Therapeutics in Rare Genetic Disease nanENROLLING_BY_INVITATION
Immunophenotyping and Xist Gene in AML nanUNKNOWN
The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis nanRECRUITING
Transcriptomic Analysis of Fibroblasts and Blood in Patients With Rare Diseases nanRECRUITING
Search for Bovine miRNA Transference to Humans nanCOMPLETED
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a RBM12 binder may also engage these)

ProteinNameSimilarity
Q5RBM8 1.000 Q5RBM8 →
Q8SQ27 1.000 Q8SQ27 →
Q8R4X3 1.000 Q8R4X3 →
Q63627 0.981 Q63627 →
Q1JPY8 0.980 Q1JPY8 →
Q91WT8 0.978 Q91WT8 →
PSPC1 Paraspeckle component 1 0.978 landscape →
O95104 0.978 O95104 →
Q5YD48 0.978 Q5YD48 →
Q1LZD9 0.978 Q1LZD9 →
Q4KLH4 0.978 Q4KLH4 →
Q9LIA4 0.977 Q9LIA4 →
Q8VIJ6 0.977 Q8VIJ6 →
Q2T9I5 0.977 Q2T9I5 →
Q923K9 0.976 Q923K9 →
A2Q848 0.976 A2Q848 →
Q2HJG2 0.976 Q2HJG2 →
O94913 0.976 O94913 →
Q6DEY7 0.976 Q6DEY7 →
PABPC4 Polyadenylate-binding protein 4 0.976 landscape →
O14102 0.976 O14102 →
Q6DDW4 0.976 Q6DDW4 →
SFPQ Splicing factor, proline- and glutamine-rich 0.975 landscape →
Q05196 0.975 Q05196 →
Q98SJ2 0.975 Q98SJ2 →
Q9VIV2 0.975 Q9VIV2 →
Q6GR16 0.975 Q6GR16 →
Q66H68 0.975 Q66H68 →
Q3UEB3 0.975 Q3UEB3 →
Q5R9H4 0.975 Q5R9H4 →